Top Markets
#1 ADO Protocol ADO Protocol +193.36%
#2 Islamic Coin Islamic Coin +155.22%
#3 GoPlus Security GoPlus Security +45.23%
#4 Siren Siren +42.82%
#5 GAIB AID GAIB AID +24.80%
#6 Casper Network Casper Network +19.86%
#7 Starpower Starpower +15.89%
#8 Verus Coin Verus Coin +13.74%
#9 o1.exchange o1.exchange +12.92%
#10 Pons Pons +12.30%
Coin of the day
ADO Protocol ADO Protocol
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Bharat Immunologicals & Biologicals Corporation Limited Bharat Immunologicals & Biologicals Corporation Limited

Bharat Immunologicals & Biologicals Corporation Limited

BIBCL
Classement en actions #33476
Bharat Immunologicals & Biologicals Corp. Ltd. operates as a biotechnology... Bharat Immunologicals & Biologicals Corp. Ltd. operates as a biotechnology enterprise, primarily involved in the development and manufacture of pharmaceutical goods. Its offerings include vital products such as oral polio vaccines, zinc tablets, comprehensive diarrhea management kits, and ready-to-consume therapeutic foods. The firm organizes its operations into several key divisions: Oral Polio Vaccine (OPV), Zinc Tablets, BIB VIT, and BIBSANIT. Founded on March 10, 1989, the company's main office is situated in Bulandshahr, India.
Prix de l'action
$0.17558081
Capitalisation boursière
$7.58M
Changement (1 jour)
-0.25%
Changement (1 an)
-30.30%
Pays
IN
Échange Bharat Immunologicals & Biologicals Corporation Limited (BIBCL)

Catégorie

Healthcare
Bénéfices pour Bharat Immunologicals & Biologicals Corporation Limited (BIBCL)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Bharat Immunologicals & Biologicals Corporation Limited, les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Bharat Immunologicals & Biologicals Corporation Limited de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US